Fennec Pharmaceuticals Inc.
FENC- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001211583
In the last 90 days, Fennec Pharmaceuticals Inc. insiders filed 0 open-market purchases and 5 sales; 105 institutions reported holding it in 13F filings for Q2 2026, worth $175.1M in total; no superinvestor holds it.
Q2 2021 vs. Q1 2021
How the institutions holding Fennec Pharmaceuticals Inc. changed between Q1 2021 and Q2 2021.
All holders in Q2 2021All holders in Q1 2021
| Measure | Q1 2021 | Q2 2021 | Change |
|---|---|---|---|
| Holders | 53 | 39 | −14 |
| Shares | 14.4M | 12.1M | −2.30M (−16.0%) |
| Value | $89.3M | $88.0M | −$1.22M (−1.4%) |
New holders (11)
Institutions that held Fennec Pharmaceuticals Inc. at the end of Q2 2021 but not at the end of Q1 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| DG Capital Management, LLC | 588,773 | $4.29M | 0.95% |
| Millennium Management LLC | 404,772 | $2.95M | 0.00% |
| Harbert Fund Advisors, Inc. | 120,851 | $881.0K | 0.49% |
| Ergoteles LLC | 92,340 | $673.0K | 0.02% |
| HRT Financial LP | 61,990 | $451.0K | 0.00% |
| Tibra Equities Europe Ltd | 46,300 | $338.0K | 0.10% |
| Jane Street Group, LLC | 24,278 | $177.0K | 0.00% |
| Renaissance Technologies LLC | 20,284 | $148.0K | 0.00% |
| ExodusPoint Capital Management, LP | 17,115 | $125.0K | 0.00% |
| Susquehanna International Group, LLP | 14,398 | $105.0K | 0.00% |
| Wealth Quarterback LLC | 1,000 | $8.00K | 0.00% |
Sold out (25)
Institutions that held Fennec Pharmaceuticals Inc. at the end of Q1 2021 and filed for Q2 2021 without it.